Analysed ASTELLAS PHARMA INC (ALPMF:OTCMKTS) News Sources
Japan Regenerative Medicine Market Trends and Forecasts to 2035 Featuring Astellas Pharma, Fujifilm, JCR Pharmaceuticals, Sumitomo Pharma, Takeda, and Terumo
13-05-2026
yahoo.com
Australia Regenerative Medicine Market Research Trends and Forecasts Report 2026-2035 Featuring Prominent Players Such as Abbott Laboratories, Astellas Pharma, and Roche
13-05-2026
yahoo.com
Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026
18-05-2026
yahoo.com
Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion
18-05-2026
yahoo.com
Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals
21-05-2026
yahoo.com
Merck Stock Climbs on Cancer Data. Why the Drugmaker Is More Than a One-Trick Pony.
22-05-2026
yahoo.com
Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company
26-05-2026
yahoo.com
What is the current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is $15.35.
ASTELLAS PHARMA INC (ALPMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is $1.1.
ASTELLAS PHARMA INC (ALPMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is 7.7193%.
What is the most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is 63 out of 100.
What is the most recent average sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The most recent sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is .
SEC-8K** Filing Available For ASTELLAS PHARMA INC (ALPMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.